https://jonfleetwood.substack.com/p/us-intelligence-classified-and-redacted?
U.S. Intelligence Classified and Redacted Findings on COVID-19 PCR Tests: New FOIA Documents
New records show top U.S. nuclear, national security laboratories scrutinized primers used to define the pandemic—but hid the results.
Newly released Department of Energy (DOE) records obtained by U.S. Right to Know through a Freedom of Information Act (FOIA) request show that U.S. federal intelligence agencies classified and redacted the results of an internal review of COVID-19 PCR test primers, even as those tests were used to define “cases,” drive emergency policy, and justify unprecedented social and economic controls.
The documents reveal that during the pandemic, the U.S. government quietly subjected PCR test primer sets—the molecular components that determine what PCR tests detect—to classified scrutiny by top national security laboratories, while withholding the findings from the public under national-security and intelligence exemptions.
At the center of the release is a classified internal communication titled “DRAFT memo on Primer Sets,” circulated through the DOE’s Office of Intelligence and Counterintelligence and reviewed by assay experts at Lawrence Livermore National Laboratory, Los Alamos National Laboratory, and Pacific Northwest National Laboratory.
The memo itself remains classified.
Its conclusions were redacted.
No public explanation was ever provided.
PCR Testing Was Treated as a Classified Intelligence Issue
PCR tests do not detect an intact virus and do not prove infection.
They work by using short genetic sequences—primers—to bind to matching genetic material and amplify it until a signal is detected.
What a PCR test detects depends entirely on what its primers bind to. (See link for article)
_______________
**Comment**
What this means is while the public was repeatedly told COVID testing was reliable, specific, and settled science, the test was never handled in a public scientific manner but as a classified intelligence issue.
This should tell you everything you need to know, but it’s actually far worse.
In 2020 we were warned about the CDC’s monopolized COVID testing – something those in Lymeland have had to live with for over 40 years.
Experts have now shown repeatedly that the genetic sequences used in PCRs to detect suspected SARS-CoV-2 as well as the flu, and to diagnose cases of illness and death attributed to Covid-19 are present in dozens of sequences of the human genome itself and in those of about a hundred microbes. And that includes the initiators or primers, the most extensive fragments taken at random from their supposed “genome” and even the so-called “target genes” allegedly specific to the “new coronavirus”.
The test is worthless and all “positive” results obtained so far should be scientifically invalidated and communicated to those affected; and if they are deceased, to their relatives. Stephen Bustin, one of the world’s leading experts on PCR, in fact says that under certain conditions anyone can test positive.
https://www.thefocalpoints.com/p/the-replacement-for-pcr-tests-has? Go here for article & video interview
The Replacement for PCR Tests Has Arrived
The COVID era exposed a diagnostic failure that can no longer be ignored: PCR-based testing is not a true “gold standard” for clinical infection diagnosis. PCR is widely treated as definitive, but mechanistically it is not an identification method—it is an amplification step that simply makes more copies of genetic material. The real weakness comes from what many systems use after amplification: probe-based fluorescence detection, which generates a “signal” without actually confirming what is present. That is how medicine ends up with false positives, misclassification, and policy decisions built on unstable data.
In my interview with Dr. Roger Hodkinson—a highly respected pathologist and Chairman of MultiSeq—he explains why the PCR problem is structural: probe-based testing functions like a “lock-and-key,” where partial matches can still trigger a positive signal. Even worse, infectious syndromes (cough/cold, diarrhea, suspected STI) are rarely caused by only one organism—yet most PCR workflows are narrow, slow, and often treated as confirmatory when they’re not. In practice, clinicians are forced into an “educated guess” model because results frequently come back days later and only cover a limited scope.
MultiSeq is attempting to replace this entire model with something fundamentally different: sequence-confirmed diagnosis. Instead of relying on probe fluorescence to “suggest” identity, it uses modified Sanger sequencing to directly read the nucleotide sequence and confirm which pathogen is actually present. (See link for article & video)
Madison Area Lyme Support Group 